Raltegravir as effective as efavirenz in 144-week data.
AIDS patient care and STDs
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
Efavirenz + TDF + FTC + versus Efavirenz + ZDV-3 TC Study 934 : Result Week 48 : Immunologic Response
May 11, 2018
Dolutegravir in Patients with Raltegravir-Resistant HIV
Apr 21, 2018
Rilpivirine (TMC-278) vs. Efavirenz, with 2NRTIs in ARV-Naive
Apr 14, 2018